US5250022A
(en)
*
|
1990-09-25 |
1993-10-05 |
Rutgers, The State University Of New Jersey |
Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
|
US5080646A
(en)
*
|
1988-10-03 |
1992-01-14 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5679399A
(en)
*
|
1987-07-17 |
1997-10-21 |
Bio Barrier, Inc. |
Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers
|
US5549924A
(en)
*
|
1987-07-17 |
1996-08-27 |
Robin Renee Thill Shlenker |
Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer
|
US5169382A
(en)
*
|
1988-10-03 |
1992-12-08 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5147296A
(en)
*
|
1988-10-03 |
1992-09-15 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5496266A
(en)
*
|
1990-04-30 |
1996-03-05 |
Alza Corporation |
Device and method of iontophoretic drug delivery
|
US4927408A
(en)
*
|
1988-10-03 |
1990-05-22 |
Alza Corporation |
Electrotransport transdermal system
|
US5240995A
(en)
*
|
1989-02-09 |
1993-08-31 |
Alza Corporation |
Electrotransport adhesive
|
US5234992A
(en)
*
|
1989-02-09 |
1993-08-10 |
Alza Corporation |
Electrotransport adhesive
|
ES2095929T3
(es)
*
|
1989-10-23 |
1997-03-01 |
Theratech Inc |
Dispositivo iontoforetico que emplea un regulador del regimen.
|
JP2816886B2
(ja)
*
|
1990-03-05 |
1998-10-27 |
興和株式会社 |
生体通電装置
|
GR1000433B
(el)
*
|
1990-04-24 |
1992-07-30 |
Alza Corp |
Συσκευη και μεθοδος ιοντοφορητικης απελευθερωσης φαρμακου.
|
US5147297A
(en)
*
|
1990-05-07 |
1992-09-15 |
Alza Corporation |
Iontophoretic delivery device
|
US5362308A
(en)
*
|
1990-09-25 |
1994-11-08 |
Rutgers, The State University Of New Jersey |
Disposable dosage unit for iontophoresis-facilitated transdermal delivery, related devices and processes
|
US5677360A
(en)
*
|
1991-02-13 |
1997-10-14 |
Mitsubishi Rayon Co., Ltd. |
Hydrophilic polymer alloy, fiber and porous membrane comprising this polymer alloy, and methods for preparing them
|
US5405317A
(en)
*
|
1991-05-03 |
1995-04-11 |
Alza Corporation |
Iontophoretic delivery device
|
US5402777A
(en)
*
|
1991-06-28 |
1995-04-04 |
Alza Corporation |
Methods and devices for facilitated non-invasive oxygen monitoring
|
US5356632A
(en)
*
|
1991-09-12 |
1994-10-18 |
S.I. Scientific Innovations Ltd. |
Transdermal drug delivery device
|
SE9102778D0
(sv)
*
|
1991-09-25 |
1991-09-25 |
Siemens Elema Ab |
Implanterbar medicinsk anordning
|
US5421816A
(en)
*
|
1992-10-14 |
1995-06-06 |
Endodermic Medical Technologies Company |
Ultrasonic transdermal drug delivery system
|
CA2126487C
(en)
*
|
1993-06-23 |
2001-05-29 |
Keiichiro Okabe |
Iontophoresis device
|
US5387189A
(en)
*
|
1993-12-02 |
1995-02-07 |
Alza Corporation |
Electrotransport delivery device and method of making same
|
US5508262A
(en)
*
|
1993-12-15 |
1996-04-16 |
University Of South Florida |
Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
|
AU2286995A
(en)
*
|
1994-04-08 |
1995-10-30 |
Alza Corporation |
Electrotransport system with ion exchange competitive ion capture
|
FR2719485B1
(fr)
*
|
1994-05-06 |
1996-07-12 |
Lhd Lab Hygiene Dietetique |
Procédé et dispositif de mesure de la quantité d'un principe actif contenu dans un réservoir.
|
JP3523334B2
(ja)
*
|
1994-07-02 |
2004-04-26 |
久光製薬株式会社 |
イオントフォレ−シス用プラスター構造体
|
US5861439A
(en)
*
|
1994-11-14 |
1999-01-19 |
Alza Corporation |
Method for enhanced electrotransport agent delivery
|
FR2726769B1
(fr)
*
|
1994-11-16 |
1997-01-31 |
Lhd Lab Hygiene Dietetique |
Dispositif ionophoretique d'administration transdermique de medicaments et ensemble jetable formant partie d'un tel dispositif
|
US5855867A
(en)
*
|
1995-03-29 |
1999-01-05 |
The Curators Of The University Of Missouri |
Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
|
IL113459A
(en)
*
|
1995-04-23 |
2000-07-16 |
Electromagnetic Bracing System |
Electrophoretic cuff apparatus
|
EP1131131A1
(de)
*
|
1995-04-23 |
2001-09-12 |
Electromagnetic Bracing Systems, Inc. |
System und verfahren zum aktiven transdermalen verabreichen einer arznei
|
US5853383A
(en)
*
|
1995-05-03 |
1998-12-29 |
Alza Corporation |
Preparation for formulations for electrotransport drug delivery
|
US6216033B1
(en)
|
1996-05-22 |
2001-04-10 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6881208B1
(en)
*
|
1995-06-05 |
2005-04-19 |
Joseph B. Phipps |
Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
|
IE960375A1
(en)
*
|
1995-06-05 |
1996-12-11 |
Alza Corp |
Device for transdermal electrotransport delivery of fentanyl¹and sufentanil
|
CA2218369C
(en)
*
|
1995-06-05 |
2010-02-09 |
Alza Corporation |
Transdermal electrotransport delivery of fentanyl and sufentanil
|
US6425892B2
(en)
|
1995-06-05 |
2002-07-30 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US5747453A
(en)
|
1995-06-06 |
1998-05-05 |
Alza Corporation |
Method for increasing the electrotransport flux of polypeptides
|
US7572252B1
(en)
|
1995-06-07 |
2009-08-11 |
Alza Corporation |
Electrotransport agent delivery method and apparatus
|
US5983130A
(en)
|
1995-06-07 |
1999-11-09 |
Alza Corporation |
Electrotransport agent delivery method and apparatus
|
US5767084A
(en)
*
|
1995-10-06 |
1998-06-16 |
The Curators Of The University Of Missouri |
Method of treatment for cystic fibrosis and peptides for same
|
AU1074897A
(en)
|
1995-11-08 |
1997-05-29 |
University Of South Florida |
Guinea pig model for leiomyomas and atherosclerosis
|
CA2242753A1
(en)
|
1996-01-30 |
1997-08-07 |
Novagent Oy |
Composition for transdermal delivery of drugs
|
US6333189B1
(en)
|
1996-06-06 |
2001-12-25 |
Alza Corporation |
Method of making an electrotransport device
|
US6718201B1
(en)
|
1996-06-07 |
2004-04-06 |
Alza Corporation |
Electrotransport agent delivery method and apparatus
|
US6230051B1
(en)
*
|
1996-06-18 |
2001-05-08 |
Alza Corporation |
Device for enhancing transdermal agent delivery or sampling
|
US5961483A
(en)
*
|
1996-06-19 |
1999-10-05 |
Sage; Burton H. |
Iontophoretic delivery of cell adhesion inhibitors
|
EP0813887A3
(de)
*
|
1996-06-20 |
1999-11-03 |
Hisamitsu Pharmaceutical Co. Inc. |
Iontophoretische Vorrichtung
|
US5871461A
(en)
*
|
1996-07-12 |
1999-02-16 |
Empi, Inc. |
Method of making an iontophoresis electrode
|
US5941843A
(en)
*
|
1996-07-12 |
1999-08-24 |
Empi, Inc. |
Iontophoresis electrode
|
US5857993A
(en)
*
|
1996-07-12 |
1999-01-12 |
Empi, Inc. |
Process of making an iontophoresis electrode
|
US6350259B1
(en)
*
|
1996-09-30 |
2002-02-26 |
Vyteris, Inc. |
Selected drug delivery profiles using competing ions
|
US5906976A
(en)
*
|
1996-10-22 |
1999-05-25 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Method and composition for treating neuronal degeneration
|
FR2755372B1
(fr)
*
|
1996-11-07 |
1998-12-24 |
Elf Aquitaine |
Dispositif d'ionophorese comportant au moins un ensemble electrode a membrane, pour l'administration transcutanee de principes actifs a un sujet
|
US6246904B1
(en)
|
1996-12-17 |
2001-06-12 |
Alza Corporation |
Electrotransport drug delivery reservoirs containing inert fillers
|
US6650934B2
(en)
|
1996-12-17 |
2003-11-18 |
Alza Corp |
Polymeric foam reservoirs for an electrotransport delivery device
|
US6119036A
(en)
|
1997-03-26 |
2000-09-12 |
The Board Of Regents Of The University Of Oklahoma |
Iontophoretic transdermal delivery device
|
US5976547A
(en)
*
|
1997-04-22 |
1999-11-02 |
Niblick Pharmaceuticals, Inc. |
Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
|
US6004577A
(en)
*
|
1997-08-12 |
1999-12-21 |
Murdock; Thomas O. |
Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
|
US6775569B2
(en)
|
1997-11-05 |
2004-08-10 |
Hisamitsu Pharmaceutical Co., Inc. |
Electroporation device for in vivo delivery of therapeutic agents
|
CN1278737A
(zh)
*
|
1997-11-12 |
2001-01-03 |
阿尔萨公司 |
减少多肽自结合的方法
|
JP3980140B2
(ja)
*
|
1997-12-04 |
2007-09-26 |
村越 寧根 |
治療器具
|
US6918901B1
(en)
|
1997-12-10 |
2005-07-19 |
Felix Theeuwes |
Device and method for enhancing transdermal agent flux
|
EP1911488A3
(de)
|
1997-12-11 |
2008-12-03 |
Alza Corporation |
Vorrichtung zur Verstärkung des Flusses transdermaler Mittel
|
ATE221400T1
(de)
*
|
1997-12-11 |
2002-08-15 |
Alza Corp |
Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
|
DK1037686T3
(da)
*
|
1997-12-11 |
2006-01-02 |
Alza Corp |
Apparat til forögelse af transdermal gennemströmning af midler
|
JP2001525227A
(ja)
|
1997-12-11 |
2001-12-11 |
アルザ・コーポレーション |
経皮的薬剤流量を高めるための装置
|
US6163720A
(en)
*
|
1997-12-18 |
2000-12-19 |
Alza Corporation |
Layered rate controlling membranes for use in an electrotransport device
|
US6374136B1
(en)
*
|
1997-12-22 |
2002-04-16 |
Alza Corporation |
Anhydrous drug reservoir for electrolytic transdermal delivery device
|
JP4154017B2
(ja)
*
|
1997-12-30 |
2008-09-24 |
久光製薬株式会社 |
イオントフォレーシス装置および薬物ユニット
|
US6489306B2
(en)
|
1998-02-23 |
2002-12-03 |
University Of South Florida |
Method of intranasal gene transfer for protection against respiratory infection
|
US6028102A
(en)
*
|
1998-02-24 |
2000-02-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Anticonvulsant drugs and pharmaceutical compositions thereof
|
US6059736A
(en)
*
|
1998-02-24 |
2000-05-09 |
Tapper; Robert |
Sensor controlled analysis and therapeutic delivery system
|
US6338834B1
(en)
|
1998-04-30 |
2002-01-15 |
The Curators Of The University Of Missouri |
Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
WO2000002561A1
(en)
|
1998-07-13 |
2000-01-20 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
US7002003B1
(en)
|
1998-07-30 |
2006-02-21 |
University Of South Florida |
Method for the inhibition of function of STAT transcription factors
|
US6780397B2
(en)
|
1998-09-01 |
2004-08-24 |
Curators Of The University Of Missouri |
Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents
|
US20050171021A1
(en)
*
|
1998-11-12 |
2005-08-04 |
Cormier Michel J. |
Buffered drug formulations for transdermal
|
US20070196490A1
(en)
*
|
1999-01-22 |
2007-08-23 |
Powderject Research Limited |
Method of enhancing needleless transdermal powered drug delivery
|
US6638974B1
(en)
|
1999-04-09 |
2003-10-28 |
University Of South Florida |
Ascorbyl esters for the treatment of cancer
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7135498B1
(en)
|
1999-06-14 |
2006-11-14 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
EP1233670B1
(de)
*
|
1999-06-14 |
2008-09-17 |
Henry Ford Health System |
Stickstoffmonoxid-donoren zum induzieren von neurogenese
|
US7655423B2
(en)
*
|
1999-06-14 |
2010-02-02 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
US6394994B1
(en)
*
|
1999-08-27 |
2002-05-28 |
Vyteris, Inc. |
Method for testing the ability of an iontophoretic reservoir-electrode to deliver a medicament
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
AU4710401A
(en)
|
1999-12-02 |
2001-06-18 |
University Of South Florida |
Method and composition for treatment of ischemic neuronal reperfusion injury
|
EP1239916B1
(de)
|
1999-12-10 |
2005-11-23 |
ALZA Corporation |
Vorrichtung und verfahren zur verbesserung des mikronadel-haut-piercing
|
US20020022594A1
(en)
*
|
2000-07-11 |
2002-02-21 |
Ping Dou |
Bax fragment induced tumor cell death
|
FR2812218B1
(fr)
*
|
2000-07-28 |
2003-01-10 |
Eastman Kodak Co |
Procede pour ameliorer le fonctionnement d'une membrane d'un dispositif de nanofiltration
|
US6803060B2
(en)
|
2000-09-07 |
2004-10-12 |
Joe Reyes |
Composition to boost libido
|
US6553255B1
(en)
|
2000-10-27 |
2003-04-22 |
Aciont Inc. |
Use of background electrolytes to minimize flux variability during iontophoresis
|
MXPA03003638A
(es)
*
|
2000-10-27 |
2004-01-26 |
Immuno Rx Inc |
Inmunoterapia con vacuna para pacientes inmunosuprimidos.
|
US20070025958A1
(en)
|
2000-10-27 |
2007-02-01 |
Hadden John W |
Vaccine immunotherapy
|
US20070154399A1
(en)
*
|
2000-10-27 |
2007-07-05 |
Hadden John W |
Immunotherapy for immune suppressed patients
|
US7182942B2
(en)
*
|
2000-10-27 |
2007-02-27 |
Irx Therapeutics, Inc. |
Vaccine immunotherapy for immune suppressed patients
|
US20060194242A1
(en)
*
|
2000-10-27 |
2006-08-31 |
Hadden John W |
Immunotherapy for immune suppressed patients
|
US20070031372A1
(en)
*
|
2004-08-05 |
2007-02-08 |
Hadden John W |
Vaccine immunotherapy for immune suppressed patients
|
EP1385571B1
(de)
*
|
2001-04-04 |
2008-07-30 |
Alza Corporation |
Transdermales verabreichungsgerät mittels elektrotransport mit einer kompatiblen antimikrobiellen reservoir-lösung
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
DE10141650C1
(de)
*
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
WO2003035004A2
(en)
*
|
2001-10-26 |
2003-05-01 |
Immuno-Rx, Inc. |
Immunotherapy for reversing immune suppression
|
US7349733B2
(en)
|
2001-11-02 |
2008-03-25 |
Ceramatel, Inc. |
Iontophoretic drug delivery systems
|
US6775570B2
(en)
|
2002-02-04 |
2004-08-10 |
Ceramatec, Inc. |
Iontophoretic treatment device
|
US7047069B2
(en)
|
2002-02-04 |
2006-05-16 |
Ceramatec, Inc. |
Iontophoretic fluid delivery device
|
DE10205373B4
(de)
*
|
2002-02-09 |
2007-07-19 |
Aloys Wobben |
Brandschutz
|
CA2500713C
(en)
|
2002-10-04 |
2012-07-03 |
Photokinetix, Inc. |
Photokinetic delivery of biologically active substances using pulsed incoherent light
|
WO2004037204A2
(en)
*
|
2002-10-25 |
2004-05-06 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
US6872292B2
(en)
*
|
2003-01-28 |
2005-03-29 |
Microlin, L.C. |
Voltage modulation of advanced electrochemical delivery system
|
US7220778B2
(en)
*
|
2003-04-15 |
2007-05-22 |
The General Hospital Corporation |
Methods and devices for epithelial protection during photodynamic therapy
|
US20050049549A1
(en)
*
|
2003-08-04 |
2005-03-03 |
Wong Patrick S.L. |
Method and device for enhancing transdermal agent flux
|
US20050049196A1
(en)
*
|
2003-08-29 |
2005-03-03 |
Michael Hutchinson |
Indirect delivery of growth factors into the central nervous system
|
US20050059610A1
(en)
*
|
2003-09-12 |
2005-03-17 |
Paul Wischmeyer |
Glutamine for use in treating injury
|
JP2007508914A
(ja)
*
|
2003-10-24 |
2007-04-12 |
アルザ・コーポレーシヨン |
経皮薬剤送達を促進するための装置及び方法
|
JP2007510445A
(ja)
|
2003-10-24 |
2007-04-26 |
アルザ・コーポレーシヨン |
経皮薬剤送達促進用の前処置法及びシステム
|
AU2004287059A1
(en)
*
|
2003-10-28 |
2005-05-19 |
Alza Corporation |
Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections
|
MXPA06005509A
(es)
*
|
2003-11-13 |
2007-05-23 |
Johnson & Johnson |
Sistema y metodo para distribucion transdermica.
|
JP2007516962A
(ja)
*
|
2003-11-19 |
2007-06-28 |
アルザ・コーポレーシヨン |
ペプチドで緩衝させた電気輸送用途用配合物および製造方法
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
EP1699448A4
(de)
*
|
2003-12-30 |
2010-11-03 |
Syndromex Ltd |
Verfahren zur verabreichung von 3,3,14,14-tetramethyl-hexadecan-1,16-dionsäure
|
EP1758998B1
(de)
|
2004-01-30 |
2010-12-15 |
Quark Pharmaceuticals, Inc. |
Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten
|
US20050220439A1
(en)
*
|
2004-03-19 |
2005-10-06 |
Carton Owen A |
Interactive multimedia system and method
|
CN101027045A
(zh)
*
|
2004-04-13 |
2007-08-29 |
阿尔扎公司 |
基于芬太尼药物的透皮释放装置和方法
|
AU2005244734A1
(en)
|
2004-05-13 |
2005-12-01 |
Alza Corporation |
Apparatus and method for transdermal delivery of parathyroid hormone agents
|
CA2566759A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Alza Corporation |
Method and formulation for transdermal delivery of immunologically active agents
|
US20060030811A1
(en)
*
|
2004-08-03 |
2006-02-09 |
Wong Patrick S |
Method and device for enhancing transdermal agent flux
|
TW200618830A
(en)
*
|
2004-08-10 |
2006-06-16 |
Alza Corp |
Micorprojection apparatus and system with low infection potential
|
JP4468989B2
(ja)
|
2004-08-16 |
2010-05-26 |
クアーク・ファーマスーティカルス、インコーポレイテッド |
Rtp801阻害剤の治療への使用
|
AR050608A1
(es)
*
|
2004-08-19 |
2006-11-08 |
Alza Corp |
Aparato y metodo para administracion transdermica de factores de crecimiento endotelial vascular
|
NZ553987A
(en)
|
2004-09-28 |
2011-01-28 |
Quark Pharmaceuticals Inc |
Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
|
JP2006116086A
(ja)
*
|
2004-10-21 |
2006-05-11 |
Tokuyama Corp |
イオントフォレーシス装置用作用極構造体及びイオントフォレーシス装置
|
US20060095001A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Transcutaneous Technologies Inc. |
Electrode and iontophoresis device
|
WO2006055729A1
(en)
*
|
2004-11-16 |
2006-05-26 |
Transcutaneous Technologies Inc. |
Iontophoretic device and method for administering immune response-enhancing agents and compositions
|
JP4728631B2
(ja)
*
|
2004-11-30 |
2011-07-20 |
Tti・エルビュー株式会社 |
イオントフォレーシス装置
|
EP1820533B1
(de)
*
|
2004-12-09 |
2011-11-02 |
TTI ellebeau, Inc. |
Iontophoretisches gerät
|
US7590444B2
(en)
*
|
2004-12-09 |
2009-09-15 |
Tti Ellebeau, Inc. |
Iontophoresis device
|
JP4731931B2
(ja)
*
|
2005-02-03 |
2011-07-27 |
Tti・エルビュー株式会社 |
イオントフォレーシス装置
|
CA2595990A1
(en)
*
|
2005-02-03 |
2006-08-10 |
Transcutaneous Technologies Inc. |
Iontophoresis device
|
AU2006214236A1
(en)
*
|
2005-02-16 |
2006-08-24 |
Alza Corporation |
Apparatus and method for transdermal delivery of erythropoetin-based agents
|
JP2008529750A
(ja)
*
|
2005-02-16 |
2008-08-07 |
アルザ コーポレイション |
生体適合性が改善されたマイクロプロジェクションアレイ
|
TW200640526A
(en)
*
|
2005-02-24 |
2006-12-01 |
Alza Corp |
Transdermal electrotransport drug delivery systems with reduced abuse potential
|
JP4793806B2
(ja)
|
2005-03-22 |
2011-10-12 |
Tti・エルビュー株式会社 |
イオントフォレーシス装置
|
JP2006296511A
(ja)
*
|
2005-04-15 |
2006-11-02 |
Transcutaneous Technologies Inc |
外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
|
JP2006334164A
(ja)
*
|
2005-06-02 |
2006-12-14 |
Transcutaneous Technologies Inc |
イオントフォレーシス装置及びその制御方法
|
WO2006130869A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Alza Corporation |
Method for terminal sterilization of transdermal delivery devices
|
US20060280644A1
(en)
*
|
2005-06-02 |
2006-12-14 |
Scott Sellers |
Method for terminal sterilization of transdermal delivery devices
|
JP2006346368A
(ja)
*
|
2005-06-20 |
2006-12-28 |
Transcutaneous Technologies Inc |
イオントフォレーシス装置及びその製造方法
|
JP2007000342A
(ja)
*
|
2005-06-23 |
2007-01-11 |
Transcutaneous Technologies Inc |
複数薬剤の投与量および投与時期を制御するイオントフォレーシス装置
|
JPWO2007010900A1
(ja)
*
|
2005-07-15 |
2009-01-29 |
Tti・エルビュー株式会社 |
貼付位置表示機能付き経皮吸収用パッチ及びイオントフォレーシス装置
|
KR100719095B1
(ko)
*
|
2005-07-29 |
2007-05-17 |
성균관대학교산학협력단 |
연료 확산속도 제어물질층을 포함하여 메탄올 크로스오버현상을 억제시킨 직접 메탄올 연료전지
|
US8295922B2
(en)
|
2005-08-08 |
2012-10-23 |
Tti Ellebeau, Inc. |
Iontophoresis device
|
US8386030B2
(en)
*
|
2005-08-08 |
2013-02-26 |
Tti Ellebeau, Inc. |
Iontophoresis device
|
US20070088332A1
(en)
*
|
2005-08-22 |
2007-04-19 |
Transcutaneous Technologies Inc. |
Iontophoresis device
|
JPWO2007023907A1
(ja)
*
|
2005-08-24 |
2009-02-26 |
Tti・エルビュー株式会社 |
冷凍型イオントフォレーシス用電極構造体
|
US20070048362A1
(en)
*
|
2005-08-29 |
2007-03-01 |
Transcutaneous Technologies Inc. |
General purpose electrolyte solution composition for iontophoresis
|
JPWO2007029611A1
(ja)
*
|
2005-09-06 |
2009-03-19 |
Tti・エルビュー株式会社 |
イオントフォレーシス装置
|
US20070112294A1
(en)
*
|
2005-09-14 |
2007-05-17 |
Transcutaneous Technologies Inc. |
Iontophoresis device
|
RU2008114490A
(ru)
|
2005-09-15 |
2009-10-20 |
ТиТиАй ЭЛЛЕБО, ИНК. (JP) |
Устройство ионтофореза стержневого типа
|
CA2619661A1
(en)
*
|
2005-09-16 |
2007-03-22 |
Tti Ellebeau, Inc. |
Catheter-type iontophoresis device
|
WO2007038028A1
(en)
*
|
2005-09-28 |
2007-04-05 |
Tti Ellebeau, Inc. |
Iontophoresis apparatus and method to deliver active agents to biological interfaces
|
JPWO2007037324A1
(ja)
*
|
2005-09-28 |
2009-04-09 |
Tti・エルビュー株式会社 |
乾燥型イオントフォレーシス用電極構造体
|
US20070135754A1
(en)
*
|
2005-09-30 |
2007-06-14 |
Hidero Akiyama |
Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same
|
WO2007041314A2
(en)
*
|
2005-09-30 |
2007-04-12 |
Tti Ellebeau, Inc. |
Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
|
JP2009509657A
(ja)
*
|
2005-09-30 |
2009-03-12 |
Tti・エルビュー株式会社 |
生体界面への活性物質の送達のイオントフォレーシス装置及び方法
|
BRPI0616771A2
(pt)
*
|
2005-09-30 |
2011-06-28 |
Tti Ellebeau Inc |
dispositivo de iontoforese para liberar múltiplos agentes ativos para interfaces biológicas
|
US20090299265A1
(en)
*
|
2005-09-30 |
2009-12-03 |
Tti Ellebeau, Inc. |
Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same
|
JP2009509659A
(ja)
*
|
2005-09-30 |
2009-03-12 |
Tti・エルビュー株式会社 |
生体界面への活性物質の送達のイオントフォレーシス装置及び方法
|
WO2007041115A1
(en)
*
|
2005-09-30 |
2007-04-12 |
Tti Ellebeau Inc. |
Method and system to detect malfunctions in an iontophoresis device that delivers active agents to biological interfaces
|
US20090187134A1
(en)
*
|
2005-09-30 |
2009-07-23 |
Hidero Akiyama |
Iontophoresis Device Controlling Amounts of a Sleep-Inducing Agent and a Stimulant to be Administered and Time at Which the Drugs are Administered
|
JP2009509677A
(ja)
*
|
2005-09-30 |
2009-03-12 |
Tti・エルビュー株式会社 |
小胞封入活性物質のイオントフォレーシス送達
|
KR20080066712A
(ko)
*
|
2005-09-30 |
2008-07-16 |
티티아이 엘뷰 가부시키가이샤 |
관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
|
US20070197955A1
(en)
*
|
2005-10-12 |
2007-08-23 |
Transcutaneous Technologies Inc. |
Mucous membrane adhesion-type iontophoresis device
|
WO2007079116A1
(en)
*
|
2005-12-28 |
2007-07-12 |
Tti Ellebeau, Inc. |
Electroosmotic pump apparatus and method to deliver active agents to biological interfaces
|
US7848801B2
(en)
*
|
2005-12-30 |
2010-12-07 |
Tti Ellebeau, Inc. |
Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
|
WO2007079189A2
(en)
*
|
2005-12-30 |
2007-07-12 |
Tti Ellebeau, Inc. |
System and method for remote based control of an iontophoresis device
|
WO2007080129A1
(en)
|
2006-01-13 |
2007-07-19 |
A Chan Holding B.V. |
Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
|
NL2000439C2
(nl)
|
2006-01-20 |
2009-03-16 |
Quark Biotech |
Therapeutische toepassingen van inhibitoren van RTP801.
|
AU2007225056A1
(en)
*
|
2006-03-15 |
2007-09-20 |
Alza Corporation |
Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia
|
US20080004564A1
(en)
*
|
2006-03-30 |
2008-01-03 |
Transcutaneous Technologies Inc. |
Controlled release membrane and methods of use
|
US20080004671A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Alza Corporation |
Vagus nerve stimulation via orally delivered apparatus
|
US20080009782A1
(en)
*
|
2006-06-28 |
2008-01-10 |
Alza Corporation |
Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
|
JP2010502954A
(ja)
|
2006-09-05 |
2010-01-28 |
Tti・エルビュー株式会社 |
化合物のイオントフォレーシス特性を評価するためのインピーダンスシステム、装置及び方法
|
EP2059298A2
(de)
*
|
2006-09-05 |
2009-05-20 |
Tti Ellebeau, Inc. |
Systeme zur transdermalen wirkstoffverabreichung sowie vorrichtungen und verfahren unter nutzung induktiver netzteile
|
BRPI0716452A2
(pt)
|
2006-09-05 |
2014-03-04 |
Tti Ellebeau Inc |
Sistemas não destrutivos, dispositivos, e métodos para avaliar dispositivos de distribuição de medicamentos de iontoforese
|
US20080260678A1
(en)
*
|
2006-10-10 |
2008-10-23 |
University Of Colorado |
Molecular band-aid
|
JP2010507387A
(ja)
|
2006-10-25 |
2010-03-11 |
クアーク・ファーマスーティカルス、インコーポレイテッド |
新規のsiRNAおよびその使用方法
|
BRPI0719353A2
(pt)
|
2006-12-01 |
2014-01-07 |
Titi Ellebeau Inc |
Sistemas, dispositivos e métodos para dispositivos de energização e/ou controle, por exemplo, dispositivos de distribuição transdérmicos
|
WO2008087884A1
(ja)
|
2007-01-16 |
2008-07-24 |
Tti Ellebeau, Inc. |
薬物投与量の予測方法及びそのプログラム
|
US20080188791A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Difiore Attilio E |
Active iontophoresis delivery system
|
RU2482841C2
(ru)
*
|
2007-05-18 |
2013-05-27 |
ТиТиАй Эллебо, Инк. |
Устройства для трансдермальной доставки, обеспечивающие улучшенное высвобождение действующего начала через биологическую поверхность
|
US8197844B2
(en)
*
|
2007-06-08 |
2012-06-12 |
Activatek, Inc. |
Active electrode for transdermal medicament administration
|
US8729121B2
(en)
|
2007-06-25 |
2014-05-20 |
Adhezion Biomedical, Llc |
Curing accelerator and method of making
|
WO2010008822A2
(en)
|
2008-06-23 |
2010-01-21 |
Adhezion Biomedical, Llc |
Cyanoacrylate tissue adhesives with desirable permeability and tensile strength
|
EP2644228A1
(de)
*
|
2007-06-27 |
2013-10-02 |
The General Hospital Corporation |
Verfahren und Vorrichtung zur optischen Unterdrückung der photodynamischen Therapie
|
DK2170403T3
(da)
|
2007-06-27 |
2014-06-16 |
Quark Pharmaceuticals Inc |
Sammensætninger og fremgangsmåder til hæmning af ekspressionen af proapoptotiske gener
|
JP5646997B2
(ja)
|
2007-10-03 |
2014-12-24 |
クォーク ファーマシューティカルズ インコーポレーティッドQuark Pharmaceuticals,Inc. |
新規siRNA構造
|
WO2009064291A1
(en)
|
2007-11-14 |
2009-05-22 |
Spartan Medical Products, Llc |
Cyanoacrylate tissue adhesives
|
US8862223B2
(en)
|
2008-01-18 |
2014-10-14 |
Activatek, Inc. |
Active transdermal medicament patch and circuit board for same
|
EP2106791A1
(de)
|
2008-03-31 |
2009-10-07 |
Biotempt B.V. |
Glutamin oder Glutamine enthaltendes Dipeptide in einer spezifischen Dosierung für die Behandlung von Entzündungen
|
CN102099475A
(zh)
*
|
2008-06-04 |
2011-06-15 |
科达治疗公司 |
用间隙连接调节化合物治疗疼痛
|
US8293838B2
(en)
|
2008-06-20 |
2012-10-23 |
Adhezion Biomedical, Llc |
Stable and sterile tissue adhesive composition with a controlled high viscosity
|
US8198344B2
(en)
|
2008-06-20 |
2012-06-12 |
Adhezion Biomedical, Llc |
Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
|
TW201026347A
(en)
*
|
2008-09-10 |
2010-07-16 |
Transcu Ltd |
Apparatus and method to dispense HPC-based viscous liquids into porous substrates, e. g., continuous web-based process
|
US8609128B2
(en)
|
2008-10-31 |
2013-12-17 |
Adhezion Biomedical, Llc |
Cyanoacrylate-based liquid microbial sealant drape
|
US9254133B2
(en)
|
2008-10-31 |
2016-02-09 |
Adhezion Biomedical, Llc |
Sterilized liquid compositions of cyanoacrylate monomer mixtures
|
US8652510B2
(en)
|
2008-10-31 |
2014-02-18 |
Adhezion Biomedical, Llc |
Sterilized liquid compositions of cyanoacrylate monomer mixtures
|
WO2010080452A2
(en)
|
2008-12-18 |
2010-07-15 |
Quark Pharmaceuticals, Inc. |
siRNA COMPOUNDS AND METHODS OF USE THEREOF
|
US8190252B2
(en)
|
2009-02-12 |
2012-05-29 |
Incube Labs, Llc |
Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
|
US8961492B2
(en)
|
2009-02-12 |
2015-02-24 |
Incube Labs, Llc |
System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
|
US9008765B2
(en)
|
2009-02-12 |
2015-04-14 |
Incube Labs, Llc |
System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
|
KR101674904B1
(ko)
|
2009-02-26 |
2016-11-10 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
중재형 약물전달 시스템과 그 방법
|
JP2012522005A
(ja)
|
2009-03-26 |
2012-09-20 |
ヘンリー フォード ヘルス システム |
神経損傷および神経変性疾患後の神経学的転帰を改善する方法
|
US20110092881A1
(en)
*
|
2009-05-08 |
2011-04-21 |
Isis Biopolymer Inc. |
Iontophoretic device with contact sensor
|
SG175341A1
(en)
*
|
2009-05-08 |
2011-11-28 |
Isis Biopolymer Inc |
Iontophoretic device with improved counterelectrode
|
WO2010144336A2
(en)
|
2009-06-08 |
2010-12-16 |
Quark Pharmaceuticals, Inc. |
Methods for treating chronic kidney disease
|
WO2010144424A2
(en)
*
|
2009-06-09 |
2010-12-16 |
Tti Ellebeau, Inc. |
Long life high capacity electrode, device, and method of manufacture
|
US8903485B2
(en)
*
|
2009-08-06 |
2014-12-02 |
Incube Labs, Llc |
Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
|
CA2776568A1
(en)
|
2009-11-26 |
2011-06-03 |
Quark Pharmaceuticals, Inc. |
Sirna compounds comprising terminal substitutions
|
US8685038B2
(en)
|
2009-12-07 |
2014-04-01 |
Incube Labs, Llc |
Iontophoretic apparatus and method for marking of the skin
|
US8778904B2
(en)
|
2009-12-09 |
2014-07-15 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the CNS
|
TWI465238B
(zh)
*
|
2009-12-09 |
2014-12-21 |
Nitto Denko Corp |
Hsp47表現之調節
|
JP5463136B2
(ja)
*
|
2009-12-22 |
2014-04-09 |
帝國製薬株式会社 |
イオントフォレーシス療法に用いる電極装置
|
WO2011084193A1
(en)
|
2010-01-07 |
2011-07-14 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide compounds comprising non-nucleotide overhangs
|
WO2011100376A2
(en)
|
2010-02-10 |
2011-08-18 |
Incube Labs, Llc |
Methods and architecture for power optimization of iontophoretic transdermal drug delivery
|
EP2538951B1
(de)
|
2010-02-22 |
2020-04-22 |
Health Enhancement Products Inc. |
Mittel und mechanismen zur vorbeugung von hypercholesterinämie
|
AU2011239636A1
(en)
|
2010-04-13 |
2012-11-22 |
Najib Babul |
Dermal pharmaceutical compositions of 1-Methyl-2',6'-pipecoloxylidide and method of use
|
US9309019B2
(en)
|
2010-05-21 |
2016-04-12 |
Adhezion Biomedical, Llc |
Low dose gamma sterilization of liquid adhesives
|
CA2801928C
(en)
|
2010-06-24 |
2018-04-10 |
Quark Pharmaceuticals, Inc. |
Double stranded rna compounds to rhoa and use thereof
|
US20140134231A1
(en)
|
2010-10-11 |
2014-05-15 |
Sanford-Burnham Medical Research Institute |
Mir-211 expression and related pathways in human melanoma
|
CA2818024C
(en)
|
2010-12-06 |
2019-09-24 |
Quark Pharmaceuticals, Inc. |
Double stranded oligonucleotide compounds comprising positional modifications
|
US9796979B2
(en)
|
2011-03-03 |
2017-10-24 |
Quark Pharmaceuticals Inc. |
Oligonucleotide modulators of the toll-like receptor pathway
|
EP2681314B1
(de)
|
2011-03-03 |
2017-11-01 |
Quark Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur behandlung von lungenerkrankungen und läsionen
|
CN103562387A
(zh)
|
2011-03-03 |
2014-02-05 |
夸克医药公司 |
Toll样受体途径的寡核苷酸调剂
|
EP3626304A1
(de)
*
|
2011-03-24 |
2020-03-25 |
Incube Labs, Llc |
System und verfahren zur zweiphasigen transdermalen iontophoretischen abgabe von therapiemitteln
|
US8428708B1
(en)
|
2012-05-21 |
2013-04-23 |
Incline Therapeutics, Inc. |
Self-test for analgesic product
|
US8781571B2
(en)
|
2011-03-31 |
2014-07-15 |
Incline Therapeutics, Inc. |
Switch validation circuit and method
|
US8428709B1
(en)
|
2012-06-11 |
2013-04-23 |
Incline Therapeutics, Inc. |
Current control for electrotransport drug delivery
|
US9731121B2
(en)
|
2011-03-31 |
2017-08-15 |
Incline Therapeutics, Inc. |
Switch validation circuit and method
|
WO2013003697A1
(en)
|
2011-06-30 |
2013-01-03 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
US20130090633A1
(en)
*
|
2011-10-07 |
2013-04-11 |
University Of Southern California |
Osmotic patch pump
|
WO2013070821A1
(en)
|
2011-11-08 |
2013-05-16 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
CN104080480A
(zh)
|
2012-01-01 |
2014-10-01 |
奇比艾企业有限公司 |
用于选择性递送治疗剂和诊断剂的endo180靶向微粒
|
CA2858630A1
(en)
|
2012-01-12 |
2013-07-18 |
Quark Pharmaceuticals, Inc. |
Combination therapy for treating hearing and balance disorders
|
WO2013110077A1
(en)
|
2012-01-19 |
2013-07-25 |
Hybrid Medical, Llc |
Topical therapeutic formulations
|
US9314571B1
(en)
*
|
2012-02-10 |
2016-04-19 |
Mphase Technologies, Inc. |
Drug delivery system
|
EP2831233A1
(de)
|
2012-03-27 |
2015-02-04 |
CoDa Therapeutics, Inc. |
Zusammensetzungen und behandlungen auf der basis von cadherin-modulation
|
CN104768567B
(zh)
|
2012-05-18 |
2017-07-11 |
奥塔哥创业有限公司 |
用于伤口愈合的联合治疗和组合物
|
SG11201407319YA
(en)
|
2012-05-23 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for treatment of inflammatory bowel disease
|
JP2015518854A
(ja)
|
2012-05-23 |
2015-07-06 |
セリックスビオ プライヴェート リミテッド |
多発性硬化症の治療のための組成物および方法
|
US20130315891A1
(en)
|
2012-05-25 |
2013-11-28 |
Matthew Charles |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
DK2854841T3
(en)
|
2012-06-04 |
2017-05-22 |
Diamedica Inc |
Kallikrein-1-glycosylation isoforms of human tissue
|
ES2651113T3
(es)
|
2012-06-25 |
2018-01-24 |
The Brigham And Women's Hospital, Inc. |
Tratamientos terapéuticos dirigidos
|
BR112015004747A2
(pt)
|
2012-09-12 |
2017-11-21 |
Quark Pharmaceuticals Inc |
moléculas oligonucleotídicas de fita dupla para p53 e métodos de uso das mesmas
|
US9611473B2
(en)
|
2012-09-12 |
2017-04-04 |
Quark Pharmaceuticals, Inc. |
Double-stranded nucleic acid compounds
|
DK2895608T3
(en)
|
2012-09-12 |
2019-01-21 |
Quark Pharmaceuticals Inc |
DOUBLE-STRENGTHED OIGONUCLEOTIDE MOLECULES FOR P53 AND PROCEDURES FOR USING IT
|
CA3178035A1
(en)
|
2012-12-24 |
2014-07-03 |
Neurogastrx, Inc. |
Methods for treating gi tract disorders
|
EP2968470B1
(de)
|
2013-03-12 |
2020-10-28 |
The General Hospital Corporation |
Modifizierte proteine mit einer müllerschen hemmersubstanz und verwendungen davon zur behandlung von krankheiten
|
WO2014201372A1
(en)
|
2013-06-13 |
2014-12-18 |
Health Enhancement Products, Inc. |
Compounds and methods for affecting cytokines
|
WO2015020960A1
(en)
|
2013-08-09 |
2015-02-12 |
Novartis Ag |
Novel lncrna polynucleotides
|
WO2015040049A1
(en)
*
|
2013-09-19 |
2015-03-26 |
Koninklijke Philips N.V. |
Treatment device for the skin using radio-frequency electric current
|
DK3079712T3
(da)
|
2013-12-11 |
2022-04-25 |
Massachusetts Gen Hospital |
Anvendelse af müllersk inhiberende substans- (mis) proteiner til kontraception og ovariereservebevarelse
|
US9421297B2
(en)
|
2014-04-02 |
2016-08-23 |
Adhezion Biomedical, Llc |
Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides
|
WO2015200369A1
(en)
|
2014-06-24 |
2015-12-30 |
Neurogastrx, Inc. |
Prodrugs of metopimazine
|
CA2976314C
(en)
|
2014-09-26 |
2021-02-23 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of epilepsy and neurological disorders
|
CN107207403A
(zh)
|
2014-09-29 |
2017-09-26 |
塞尔利克斯生物私人有限公司 |
用于治疗多发性硬化的组合物和方法
|
WO2016067297A1
(en)
|
2014-10-27 |
2016-05-06 |
Cellix Bio Private Limited |
Salts of valproic acid with piperazine, ethylenediamine, lysine and/or eicosapentaenoic ecid (epa) amine derivatives for the treatment of epilepsy
|
CA2965449C
(en)
|
2014-10-27 |
2020-11-10 |
Cellix Bio Private Limited |
Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
|
SG11201704282UA
(en)
|
2014-12-01 |
2017-06-29 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of multiple sclerosis
|
CN107873024A
(zh)
|
2015-02-09 |
2018-04-03 |
塞尔利克斯生物私人有限公司 |
用于治疗粘膜炎的组合物和方法
|
CA3011687A1
(en)
|
2015-02-16 |
2016-08-25 |
Zivo Bioscience, Inc. |
Methods of modulating immune and inflammatory responses via administration of an algal biomass
|
FR3034017B1
(fr)
*
|
2015-03-24 |
2018-11-02 |
Feeligreen |
Matrice polymerique adhesive pour iontophorese et dispositif pour l'iontophorese comprenant ladite matrice
|
US11806375B2
(en)
|
2016-02-16 |
2023-11-07 |
Zivo Bioscience, Inc. |
Nutritional support for animals via administration of an algal derived supplement
|
WO2017143345A1
(en)
|
2016-02-19 |
2017-08-24 |
Zp Opco, Inc. |
Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
|
RU2751770C2
(ru)
|
2016-08-11 |
2021-07-16 |
Селликс Био Прайвет Лимитед |
Композиции и способы лечения синдрома раздраженного кишечника
|
US11643419B2
(en)
|
2016-10-04 |
2023-05-09 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of xerostomia
|
BR112019010816A2
(pt)
|
2016-11-28 |
2019-10-01 |
Cellix Bio Private Ltd |
composto de fórmula i, composto de fórmula ii, composto de fórmula iii, composto de fórmula iv, composto de fórmula v, composição farmacêutica, compostos, composto de fórmula viii, composto de fórmula ix, e composto de fórmula x
|
EP3554494A4
(de)
|
2016-12-19 |
2021-02-17 |
Cellixbio Private Limited |
Zusammensetzungen und verfahren zur behandlung von entzündungen
|
CN110446501A
(zh)
|
2017-03-09 |
2019-11-12 |
代阿麦迪卡股份有限公司 |
组织激肽释放酶1的剂型
|
KR20210155817A
(ko)
|
2017-08-23 |
2021-12-23 |
조사노 파마 코포레이션 |
편두통 및 군발성 두통의 치료를 위한 졸미트립탄의 치료적 농도를 신속하게 달성하는 방법
|
US11660264B2
(en)
|
2017-08-23 |
2023-05-30 |
Emergex USA Corporation |
Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
|
US10882042B2
(en)
|
2017-10-18 |
2021-01-05 |
E Ink Corporation |
Digital microfluidic devices including dual substrates with thin-film transistors and capacitive sensing
|
JP7038437B2
(ja)
|
2017-11-17 |
2022-03-18 |
セリックス バイオ プライヴェート リミテッド |
眼障害及び皮膚疾患の処置のための化合物、組成物、及び方法
|
CA3081553C
(en)
|
2017-11-17 |
2022-11-15 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of eye disorders
|
US11660265B2
(en)
|
2018-06-28 |
2023-05-30 |
Emergex USA Corporation |
Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
|
US11724024B2
(en)
*
|
2018-07-24 |
2023-08-15 |
University Of Maryland, College Park |
Inverted battery devices, and systems and methods for use thereof
|
US11353759B2
(en)
|
2018-09-17 |
2022-06-07 |
Nuclera Nucleics Ltd. |
Backplanes with hexagonal and triangular electrodes
|
US11511096B2
(en)
|
2018-10-15 |
2022-11-29 |
E Ink Corporation |
Digital microfluidic delivery device
|
US10836757B1
(en)
|
2020-04-02 |
2020-11-17 |
Neurogastrx, Inc. |
Polymorphic forms of metopimazine
|
EP3922720A1
(de)
|
2020-06-09 |
2021-12-15 |
Universidad de Murcia |
Therapie zur verhinderung unerwünschter kardialer remodellierung nach einem akuten myokardinfarkt
|
JP2024501948A
(ja)
*
|
2020-12-30 |
2024-01-17 |
ジョージア テック リサーチ コーポレイション |
医療診断のための汗の誘導のための方法及びデバイス
|
US20220265582A1
(en)
|
2021-02-24 |
2022-08-25 |
Universitätsspital Basel |
Effects of mescaline and of mescaline analogs (scalines) to assist psychotherapy
|
US11801256B2
(en)
|
2021-06-08 |
2023-10-31 |
Universitätsspital Basel |
Antidepressant-psilocybin co-treatment to assist psychotherapy
|